Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CryoLife Inc (NYSE:CRY)

10.76
Delayed Data
As of 4:02pm ET
 -0.21 / -1.91%
Today’s Change
9.16
Today|||52-Week Range
12.29
-5.03%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$311.4M

Company Description

CryoLife, Inc. is a medical devices company, which preserved human cardiac and vascular tissues, surgical adhesives and sealants, cardiac lasers and implantable end-stage renal disease access grafts for the repair of complex cardiac and vascular reconstruction surgeries. It manufactures, distributes implantable living human tissues for use in cardiac and vascular surgeries. The company operates its business trough two segments: Medical Devices and Preservation Services. The Medical Devices segment includes marketing and distribution of BioGlue, BioFoam, PerClot, HemoStase and other. The Preservation Services segment preserves human cardiac and vascular tissue to implanting institutions throughout the United States, Canada and Europe. CryoLife was founded by Steven G. Anderson on January 19, 1984 and is headquartered in Kennesaw, GA.

Contact Information

CryoLife, Inc.
1655 Roberts Boulevard NW
Kennesaw Georgia 30144-3632
P:(770) 419-3355
Investor Relations:

Employees

Shareholders

Mutual fund holders33.40%
Other institutional28.58%
Individual stakeholders20.73%

Top Executives

James Patrick MackinChairman, President & Chief Executive Officer
David Ashley LeeExecutive VP, Chief Operating & Financial Officer
Scott B. CappsVice President-Clinical Research
David C. GaleVice President-Research & Development
Jean F. HollowaySecretary, Vice President & General Counsel